Urology
Volume 57, Issue 4, Supplement 1 , Pages 56-63, April 2001

Prostate cancer prevention agent development: Criteria and pipeline for candidate chemoprevention agents

  • William G Nelson

      Affiliations

    • Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    • Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    • Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    • Department of Pharmacology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    • Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA (WGN)
    • Corresponding Author InformationReprint requests: William G. Nelson, MD, PhD, Marburg 411, The Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287
    • ,
  • George Wilding

      Affiliations

    • Department of Medicine, University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, USA (GW)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0090-4295(00)00942-0

Urology
Volume 57, Issue 4, Supplement 1 , Pages 56-63, April 2001

Article Tools